NCCN task force report

Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines

George D. Demetri, Robert S. Benjamin, Charles D. Blanke, Jean Yves Blay, Paolo Casali, Haesun Choi, Christopher L. Corless, Maria Debiec-Rychter, Ronald P. DeMatteo, David S. Ettinger, George A. Fisher, Christopher D M Fletcher, Alessandro Gronchi, Peter Hohenberger, Miranda Hughes, Heikki Joensuu, Ian Judson, Axel Le Cesne, Robert G. Maki, Michael Morse & 9 others Alberto S. Pappo, Peter W T Pisters, Chandrajit P. Raut, Peter Reichardt, Douglas Tyler, Annick D. Van Den Abbeele, Margaret Von Mehren, Jeffrey D. Wayne, John Zalcberg

Research output: Contribution to journalArticle

441 Citations (Scopus)

Abstract

The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST Task Force is composed of NCCN faculty and other key experts from the United States, Europe, and Australia. The Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize our understanding and treatment of GIST.

Original languageEnglish (US)
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume5
Issue numberSUPPL. 2
StatePublished - 2007
Externally publishedYes

Fingerprint

Gastrointestinal Stromal Tumors
Advisory Committees
Practice Guidelines
Sarcoma
Guidelines
Radiation Oncology
Medical Oncology
Molecular Pathology
Patient Care
Therapeutics

Keywords

  • Abdominal tumor
  • CD117
  • Gastric mass
  • Gastrointestinal stromal tumor
  • Gastrointestinal tract
  • GIST
  • Imatinib
  • KIT
  • Liver metastasis
  • NCCN Clinical Practice Guidelines
  • Sarcoma
  • Small bowel tumor
  • Stomach cancer
  • Sunitinib
  • Tyrosine kinase

ASJC Scopus subject areas

  • Oncology

Cite this

NCCN task force report : Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines. / Demetri, George D.; Benjamin, Robert S.; Blanke, Charles D.; Blay, Jean Yves; Casali, Paolo; Choi, Haesun; Corless, Christopher L.; Debiec-Rychter, Maria; DeMatteo, Ronald P.; Ettinger, David S.; Fisher, George A.; Fletcher, Christopher D M; Gronchi, Alessandro; Hohenberger, Peter; Hughes, Miranda; Joensuu, Heikki; Judson, Ian; Le Cesne, Axel; Maki, Robert G.; Morse, Michael; Pappo, Alberto S.; Pisters, Peter W T; Raut, Chandrajit P.; Reichardt, Peter; Tyler, Douglas; Van Den Abbeele, Annick D.; Von Mehren, Margaret; Wayne, Jeffrey D.; Zalcberg, John.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 5, No. SUPPL. 2, 2007.

Research output: Contribution to journalArticle

Demetri, GD, Benjamin, RS, Blanke, CD, Blay, JY, Casali, P, Choi, H, Corless, CL, Debiec-Rychter, M, DeMatteo, RP, Ettinger, DS, Fisher, GA, Fletcher, CDM, Gronchi, A, Hohenberger, P, Hughes, M, Joensuu, H, Judson, I, Le Cesne, A, Maki, RG, Morse, M, Pappo, AS, Pisters, PWT, Raut, CP, Reichardt, P, Tyler, D, Van Den Abbeele, AD, Von Mehren, M, Wayne, JD & Zalcberg, J 2007, 'NCCN task force report: Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, no. SUPPL. 2.
Demetri, George D. ; Benjamin, Robert S. ; Blanke, Charles D. ; Blay, Jean Yves ; Casali, Paolo ; Choi, Haesun ; Corless, Christopher L. ; Debiec-Rychter, Maria ; DeMatteo, Ronald P. ; Ettinger, David S. ; Fisher, George A. ; Fletcher, Christopher D M ; Gronchi, Alessandro ; Hohenberger, Peter ; Hughes, Miranda ; Joensuu, Heikki ; Judson, Ian ; Le Cesne, Axel ; Maki, Robert G. ; Morse, Michael ; Pappo, Alberto S. ; Pisters, Peter W T ; Raut, Chandrajit P. ; Reichardt, Peter ; Tyler, Douglas ; Van Den Abbeele, Annick D. ; Von Mehren, Margaret ; Wayne, Jeffrey D. ; Zalcberg, John. / NCCN task force report : Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2007 ; Vol. 5, No. SUPPL. 2.
@article{1c45f38b77d44118991835ebd74c6e4d,
title = "NCCN task force report: Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines",
abstract = "The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST Task Force is composed of NCCN faculty and other key experts from the United States, Europe, and Australia. The Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize our understanding and treatment of GIST.",
keywords = "Abdominal tumor, CD117, Gastric mass, Gastrointestinal stromal tumor, Gastrointestinal tract, GIST, Imatinib, KIT, Liver metastasis, NCCN Clinical Practice Guidelines, Sarcoma, Small bowel tumor, Stomach cancer, Sunitinib, Tyrosine kinase",
author = "Demetri, {George D.} and Benjamin, {Robert S.} and Blanke, {Charles D.} and Blay, {Jean Yves} and Paolo Casali and Haesun Choi and Corless, {Christopher L.} and Maria Debiec-Rychter and DeMatteo, {Ronald P.} and Ettinger, {David S.} and Fisher, {George A.} and Fletcher, {Christopher D M} and Alessandro Gronchi and Peter Hohenberger and Miranda Hughes and Heikki Joensuu and Ian Judson and {Le Cesne}, Axel and Maki, {Robert G.} and Michael Morse and Pappo, {Alberto S.} and Pisters, {Peter W T} and Raut, {Chandrajit P.} and Peter Reichardt and Douglas Tyler and {Van Den Abbeele}, {Annick D.} and {Von Mehren}, Margaret and Wayne, {Jeffrey D.} and John Zalcberg",
year = "2007",
language = "English (US)",
volume = "5",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "SUPPL. 2",

}

TY - JOUR

T1 - NCCN task force report

T2 - Management of patients with Gastrointestinal Stromal Tumor (GIST) - Update of the NCCN clinical practice guidelines

AU - Demetri, George D.

AU - Benjamin, Robert S.

AU - Blanke, Charles D.

AU - Blay, Jean Yves

AU - Casali, Paolo

AU - Choi, Haesun

AU - Corless, Christopher L.

AU - Debiec-Rychter, Maria

AU - DeMatteo, Ronald P.

AU - Ettinger, David S.

AU - Fisher, George A.

AU - Fletcher, Christopher D M

AU - Gronchi, Alessandro

AU - Hohenberger, Peter

AU - Hughes, Miranda

AU - Joensuu, Heikki

AU - Judson, Ian

AU - Le Cesne, Axel

AU - Maki, Robert G.

AU - Morse, Michael

AU - Pappo, Alberto S.

AU - Pisters, Peter W T

AU - Raut, Chandrajit P.

AU - Reichardt, Peter

AU - Tyler, Douglas

AU - Van Den Abbeele, Annick D.

AU - Von Mehren, Margaret

AU - Wayne, Jeffrey D.

AU - Zalcberg, John

PY - 2007

Y1 - 2007

N2 - The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST Task Force is composed of NCCN faculty and other key experts from the United States, Europe, and Australia. The Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize our understanding and treatment of GIST.

AB - The NCCN Soft Tissue Sarcoma Guidelines include a subsection about treatment recommendations for gastrointestinal stromal tumors (GISTs). The standard of practice rapidly changed after the introduction of effective molecularly targeted therapy (such as imatinib and sunitinib) for GIST. Because of these changes, NCCN organized a multidisciplinary panel composed of experts in the fields of medical oncology, molecular diagnostics, pathology, radiation oncology, and surgery to discuss the optimal approach for the care of patients with GIST at all stages of the disease. The GIST Task Force is composed of NCCN faculty and other key experts from the United States, Europe, and Australia. The Task Force met for the first time in October 2003 and again in December 2006 with the purpose of expanding on the existing NCCN guidelines for gastrointestinal sarcomas and identifying areas of future research to optimize our understanding and treatment of GIST.

KW - Abdominal tumor

KW - CD117

KW - Gastric mass

KW - Gastrointestinal stromal tumor

KW - Gastrointestinal tract

KW - GIST

KW - Imatinib

KW - KIT

KW - Liver metastasis

KW - NCCN Clinical Practice Guidelines

KW - Sarcoma

KW - Small bowel tumor

KW - Stomach cancer

KW - Sunitinib

KW - Tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=34447557780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447557780&partnerID=8YFLogxK

M3 - Article

VL - 5

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - SUPPL. 2

ER -